These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32498744)

  • 21. Comparing the COVID-19 Responses in Cuba and the United States.
    Powell MA; Erwin PC; Bermejo PM
    Am J Public Health; 2021 Dec; 111(12):2186-2193. PubMed ID: 34878871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long road.
    Cohen J
    Science; 2021 Feb; 371(6531):768-772. PubMed ID: 33602838
    [No Abstract]   [Full Text] [Related]  

  • 23. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Audio Interview: Planning for the SARS-CoV-2 Vaccine Rollout.
    Rubin EJ; Baden LR; Lee TH; Morrissey S
    N Engl J Med; 2021 Jan; 384(1):e13. PubMed ID: 33406335
    [No Abstract]   [Full Text] [Related]  

  • 25. Population Immunity Against COVID-19 in the United States.
    Moghadas SM; Sah P; Shoukat A; Meyers LA; Galvani AP
    Ann Intern Med; 2021 Nov; 174(11):1586-1591. PubMed ID: 34516275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Audio Interview: Do We Have the Tools to End the Covid-19 Pandemic?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Nov; 385(19):e78. PubMed ID: 34731543
    [No Abstract]   [Full Text] [Related]  

  • 27. Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country.
    Molenberghs G; Buyse M; Abrams S; Hens N; Beutels P; Faes C; Verbeke G; Van Damme P; Goossens H; Neyens T; Herzog S; Theeten H; Pepermans K; Abad AA; Van Keilegom I; Speybroeck N; Legrand C; De Buyser S; Hulstaert F
    Contemp Clin Trials; 2020 Dec; 99():106189. PubMed ID: 33132155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa.
    Gray G; Van der Heever A; Madhi S; McIntyre J; Kana B; Stevens W; Sanne I; Richards G; Abdullah F; Mendelson M; Dasoo A; Nel J; Wulfsohn A; Blumberg L; Venter F
    S Afr Med J; 2020 Dec; 111(2):89-94. PubMed ID: 33944712
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19's First Year: A Bipartisan Appraisal.
    Benjamin GC
    Am J Public Health; 2021 Apr; 111(4):542-543. PubMed ID: 33689426
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 vaccine exclusion based on legal residence is unwise and unethical.
    Lee LM; Lowe AE; Wynia MK
    J Public Health Policy; 2021 Jun; 42(2):346-349. PubMed ID: 33941847
    [No Abstract]   [Full Text] [Related]  

  • 31. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Risk Factors for COVID-19 Among People With Substance Use Disorders.
    Wen H; Barnett ML; Saloner B
    Psychiatr Serv; 2020 Dec; 71(12):1308. PubMed ID: 33019859
    [No Abstract]   [Full Text] [Related]  

  • 33. The Coronavirus Pandemic 1 Year On-What Went Wrong?
    Gostin LO
    JAMA; 2021 Mar; 325(12):1132-1133. PubMed ID: 33755061
    [No Abstract]   [Full Text] [Related]  

  • 34. Audio Interview: How Much Protection Does Prior SARS-CoV-2 Infection Provide?
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2021 Dec; 385(25):e100. PubMed ID: 34910868
    [No Abstract]   [Full Text] [Related]  

  • 35. COVID-19 vaccination for children: may be necessary for the full eradication of the disease.
    Praticò AD; Ruggieri M
    Pediatr Res; 2021 Dec; 90(6):1102-1103. PubMed ID: 34253861
    [No Abstract]   [Full Text] [Related]  

  • 36. The accelerating COVID-19 epidemic in Sudan.
    Mukhtar MM; Khogali M
    Nat Immunol; 2021 Jul; 22(7):797-798. PubMed ID: 34035525
    [No Abstract]   [Full Text] [Related]  

  • 37. Putting equity at the heart of the US government's rollout of covid tests and masks.
    Wallace DD; Urquiza K; Raifman J; Ko M
    BMJ; 2022 Feb; 376():o344. PubMed ID: 35135808
    [No Abstract]   [Full Text] [Related]  

  • 38. The Potential Future of the COVID-19 Pandemic: Will SARS-CoV-2 Become a Recurrent Seasonal Infection?
    Murray CJL; Piot P
    JAMA; 2021 Apr; 325(13):1249-1250. PubMed ID: 33656519
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccines and variants: Modelling insights into emerging issues in COVID-19 epidemiology.
    Caldwell JM; Le X; McIntosh L; Meehan MT; Ogunlade S; Ragonnet R; O'Neill GK; Trauer JM; McBryde ES
    Paediatr Respir Rev; 2021 Sep; 39():32-39. PubMed ID: 34417121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A glimmer of hope beyond the spring for Europe.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2021 Apr; 21(4):439. PubMed ID: 33721563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.